Digestive Disease Interventions 2019; 03(03): 184-192
DOI: 10.1055/s-0039-1693166
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Congenital Hepatic Vascular Anomalies

Rush H. Chewning
1   Division of Vascular and Interventional Radiology, Department of Radiology, Boston Children's Hospital, Boston, Massachusetts
› Author Affiliations
Further Information

Publication History

04 April 2019

15 May 2019

Publication Date:
13 August 2019 (online)

Abstract

Congenital hepatic vascular anomalies, following the classification system originally proposed by Mulliken and Glowacki and subsequently developed by the International Society for the Study of Vascular Anomalies, are characterized as either tumors or malformations. The former includes infantile hemangioma, congenital hemangioma, angiosarcoma, and epithelioid hemangioendothelioma. The latter includes arterioportal fistula, portosystemic shunt, arteriovenous malformation, and venous malformation. Despite this well-established system, there still exists confusion in terminology that can lead to delayed diagnosis or improper treatment. Knowledge of the clinical presentation and imaging characteristics of these entities, as well as the nosologic system for vascular anomalies, is essential in arriving at the correct diagnosis, which in turn informs proper treatment.

 
  • References

  • 1 Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69 (03) 412-422
  • 2 International Society for the Study of Vascular Anomalies. Available at: issva.org/classification . Published 2018. Updated May 2018. Accessed April 2, 2019
  • 3 Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg 2000; 37 (08) 517-584
  • 4 Hsi Dickie B, Fishman SJ, Azizkhan RG. Hepatic vascular tumors. Semin Pediatr Surg 2014; 23 (04) 168-172
  • 5 Gnarra M, Behr G, Kitajewski A. , et al. History of the infantile hepatic hemangioma: from imaging to generating a differential diagnosis. World J Clin Pediatr 2016; 5 (03) 273-280
  • 6 Kassarjian A, Dubois J, Burrows PE. Angiographic classification of hepatic hemangiomas in infants. Radiology 2002; 222 (03) 693-698
  • 7 Christison-Lagay ER, Burrows PE, Alomari A. , et al. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 2007; 42 (01) 62-67 , discussion 67–68
  • 8 Kulungowski AM, Alomari AI, Chawla A, Christison-Lagay ER, Fishman SJ. Lessons from a liver hemangioma registry: subtype classification. J Pediatr Surg 2012; 47 (01) 165-170
  • 9 Rivard DC, Lowe LH. Radiological reasoning: multiple hepatic masses in an infant. AJR Am J Roentgenol 2008; 190 (6, Suppl) S46-S52
  • 10 Gitlow SE, Bertani LM, Rausen A, Gribetz D, Dziedzic SW. Diagnosis of neuroblastoma by qualitative and quantitative determination of catecholamine metabolites in urine. Cancer 1970; 25 (06) 1377-1383
  • 11 Huang SA, Tu HM, Harney JW. , et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000; 343 (03) 185-189
  • 12 Ruppe MD, Huang SA, Jan de Beur SM. Consumptive hypothyroidism caused by paraneoplastic production of type 3 iodothyronine deiodinase. Thyroid 2005; 15 (12) 1369-1372
  • 13 Drolet BA, Frommelt PC, Chamlin SL. , et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 2013; 131 (01) 128-140
  • 14 Dickie B, Dasgupta R, Nair R. , et al. Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg 2009; 44 (01) 125-133
  • 15 Boon LM, Burrows PE, Paltiel HJ. , et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr 1996; 129 (03) 346-354
  • 16 Krol A, MacArthur CJ. Congenital hemangiomas: rapidly involuting and noninvoluting congenital hemangiomas. Arch Facial Plast Surg 2005; 7 (05) 307-311
  • 17 Roebuck D, Sebire N, Lehmann E, Barnacle A. Rapidly involuting congenital haemangioma (RICH) of the liver. Pediatr Radiol 2012; 42 (03) 308-314
  • 18 Zenzen W, Perez-Atayde AR, Elisofon SA, Kim HB, Alomari AI. Hepatic failure in a rapidly involuting congenital hemangioma of the liver: failure of embolotherapy. Pediatr Radiol 2009; 39 (10) 1118-1123
  • 19 Drut RM, Drut R. Extracutaneous infantile haemangioma is also Glut1 positive. J Clin Pathol 2004; 57 (11) 1197-1200
  • 20 Enjolras O, Mulliken JB, Boon LM, Wassef M, Kozakewich HP, Burrows PE. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg 2001; 107 (07) 1647-1654
  • 21 Hernández F, Navarro M, Encinas JL. , et al. The role of GLUT1 immunostaining in the diagnosis and classification of liver vascular tumors in children. J Pediatr Surg 2005; 40 (05) 801-804
  • 22 Mulliken JB, Enjolras O. Congenital hemangiomas and infantile hemangioma: missing links. J Am Acad Dermatol 2004; 50 (06) 875-882
  • 23 Marler JJ, Fishman SJ, Upton J. , et al. Prenatal diagnosis of vascular anomalies. J Pediatr Surg 2002; 37 (03) 318-326
  • 24 Chung EM, Lattin Jr GE, Cube R. , et al. From the archives of the AFIP: pediatric liver masses: radiologic-pathologic correlation. Part 2. Malignant tumors. Radiographics 2011; 31 (02) 483-507
  • 25 Nord KM, Kandel J, Lefkowitch JH. , et al. Multiple cutaneous infantile hemangiomas associated with hepatic angiosarcoma: case report and review of the literature. Pediatrics 2006; 118 (03) e907-e913
  • 26 Guérin F, Blanc T, Gauthier F, Abella SF, Branchereau S. Congenital portosystemic vascular malformations. Semin Pediatr Surg 2012; 21 (03) 233-244
  • 27 Chaudry G, Lillis AP, Shaikh R, Padua HM, Chewning RH, Alomari AI. Endovascular treatment of congenital arterioportal fistulas. Cardiovasc Intervent Radiol 2018; 41 (07) 1021-1028
  • 28 Norton SP, Jacobson K, Moroz SP. , et al. The congenital intrahepatic arterioportal fistula syndrome: elucidation and proposed classification. J Pediatr Gastroenterol Nutr 2006; 43 (02) 248-255
  • 29 Zhang DY, Weng SQ, Dong L, Shen XZ, Qu XD. Portal hypertension induced by congenital hepatic arterioportal fistula: report of four clinical cases and review of the literature. World J Gastroenterol 2015; 21 (07) 2229-2235
  • 30 Burdall OC, Grammatikopoulos T, Sellars M, Hadzic N, Davenport M. Congenital vascular malformations of the liver: an association with trisomy 21. J Pediatr Gastroenterol Nutr 2016; 63 (06) e141-e146
  • 31 Davenport M. Congenital vascular malformations of the liver: an association with trisomy 21. J Pediatr Gastroenterol Nutr 2017; 64 (03) e82
  • 32 Hu GH, Shen LG, Yang J, Mei JH, Zhu YF. Insight into congenital absence of the portal vein: is it rare?. World J Gastroenterol 2008; 14 (39) 5969-5979
  • 33 Ohno T, Muneuchi J, Ihara K. , et al. Pulmonary hypertension in patients with congenital portosystemic venous shunt: a previously unrecognized association. Pediatrics 2008; 121 (04) e892-e899
  • 34 Saxena AK, Sodhi KS, Arora J, Thapa BR, Suri S. Congenital intrahepatic portosystemic venous shunt in an infant with down syndrome. AJR Am J Roentgenol 2004; 183 (06) 1783-1784
  • 35 Tyraskis A, Durkin N, Davenport M. Congenital vascular anomalies of the liver. S Afr Med J 2017; 107 (10) 12130
  • 36 Grimaldi C, Monti L, Falappa P, d'Ambrosio G, Manca A, de Ville de Goyet J. Congenital intrahepatic portohepatic shunt managed by interventional radiologic occlusion: a case report and literature review. J Pediatr Surg 2012; 47 (02) e27-e31
  • 37 Scalabre A, Gorincour G, Hery G, Gamerre M, Guys JM, de Lagausie P. Evolution of congenital malformations of the umbilical-portal-hepatic venous system. J Pediatr Surg 2012; 47 (08) 1490-1495
  • 38 Gallego C, Velasco M, Marcuello P, Tejedor D, De Campo L, Friera A. Congenital and acquired anomalies of the portal venous system. Radiographics 2002; 22 (01) 141-159
  • 39 Gupta P, Sinha A, Sodhi KS. , et al. Congenital extrahepatic portosystemic shunts: spectrum of findings on ultrasound, computed tomography, and magnetic resonance imaging. Radiol Res Pract 2015; 2015: 181958
  • 40 Gallego C, Miralles M, Marín C, Muyor P, González G, García-Hidalgo E. Congenital hepatic shunts. Radiographics 2004; 24 (03) 755-772
  • 41 DeLeve LD, Valla DC, Garcia-Tsao G. ; American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology 2009; 49 (05) 1729-1764
  • 42 Isaacs Jr H. Fetal and neonatal hepatic tumors. J Pediatr Surg 2007; 42 (11) 1797-1803
  • 43 Knudson RP, Alden ER. Symptomatic arteriovenous malformation in infants less than 6 months of age. Pediatrics 1979; 64 (02) 238-241
  • 44 Castel P, Carmona FJ, Grego-Bessa J. , et al. Somatic PIK3CA mutations as a driver of sporadic venous malformations. Sci Transl Med 2016; 8 (332) 332ra42
  • 45 Limaye N, Kangas J, Mendola A. , et al. Somatic activating PIK3CA mutations cause venous malformation. Am J Hum Genet 2015; 97 (06) 914-921
  • 46 Kassarjian A, Zurakowski D, Dubois J, Paltiel HJ, Fishman SJ, Burrows PE. Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol 2004; 182 (03) 785-795
  • 47 Knipe H, Yang N. Giant hepatic venous malformation. Available at: https://radiopaedia.org/articles/giant-hepatic-venous-malformation?lang=us . Accessed April 2, 2019
  • 48 Evans J, Sabih DE. Hemangioma, Cavernous Liver. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2019
  • 49 Filtes J, Bailey C, Mitchell S, Weiss C. Abstract No. 594 Percutaneous sclerotherapy for the treatment of giant hepatic venous malformations (giant/cavernous hemangiomas). J Vasc Interv Radiol 2019; 30 (03) S256